Sana Monitoring S.R.L.
- Address
- lock Available on a paid plan
Reumatologie and Immune-Mediated Disease Research
At Sana Monitoring S.R.L. in Bucharest, the clinical trial portfolio in rheumatology focuses on immune system diseases and related inflammatory conditions, especially systemic lupus erythematosus. These studies are designed to evaluate new treatment options, measure disease control, and better understand safety and tolerability in people living with chronic autoimmune illness.
- Testing new therapies for systemic lupus erythematosus and assessing whether they can improve disease activity
- Evaluating safety and tolerability in immune-mediated and inflammatory conditions
- Supporting the development of more effective approaches for long-term autoimmune disease management
This area reflects a strong interest in improving outcomes for patients with complex rheumatologic and immunological disorders.
Musculoskeletal and Pain-Related Studies
The site also conducts research in musculoskeletal diseases, including osteoarthritis of the knee, with a focus on pain relief and treatment safety. These trials aim to find better ways to ease joint discomfort and improve daily function for people affected by degenerative joint disease.
- Studying osteoarthritis to assess pain reduction and tolerability of emerging therapies
- Exploring treatment options that may improve mobility and quality of life
- Advancing care for chronic joint disease and related pain syndromes
This research supports broader efforts in rheumatology to improve symptom control and functional outcomes.
Cardiometabolic and Metabolic Disease Research
Clinical studies at this site include cardiovascular diseases and nutritional and metabolic diseases, with work in atherosclerotic cardiovascular disease and non-alcoholic steatohepatitis. The purpose of these trials is to test new therapies that may reduce major cardiovascular events and improve liver health in people with long-term metabolic risk.
- Evaluating treatments for atherosclerotic cardiovascular disease and prevention of serious heart and stroke events
- Studying non-alcoholic steatohepatitis to assess liver improvement and disease progression
- Investigating therapies that address linked cardiometabolic risks
The Sana Monitoring S.R.L. program shows a clear emphasis on reducing long-term complications in both heart and metabolic disease.
Respiratory and Viral Infection Studies
Research in respiratory tract diseases includes asthma and chronic obstructive pulmonary disease, while virus diseases include COVID-19. These trials are aimed at improving breathing symptoms, evaluating treatment effectiveness, and assessing safety in both chronic lung disease and acute viral illness.
- Testing therapies for asthma and COPD to improve lung function and symptom control
- Studying COVID-19 treatments to reduce serious illness and hospitalization
- Building evidence for better management of respiratory and infectious diseases
This mix of studies highlights interest in both chronic airway disease and emerging viral infection care.
Endocrine, Ophthalmology, and Rare Disease Research
The site is also active in genetic phenomena and reproductive and urinary physiological phenomena, with trials in classic congenital adrenal hyperplasia, thyroid eye disease, diabetic retinopathy, and pregnancy prevention. These studies are intended to test new therapies, improve long-term eye outcomes, and evaluate reproductive health options.
- Investigating classic congenital adrenal hyperplasia to better manage hormone-related disease
- Studying thyroid eye disease and diabetic retinopathy to improve eye-related outcomes
- Assessing contraceptive effectiveness and broader reproductive health needs
This research combines endocrinology, ophthalmology, and reproductive medicine in a way that supports both symptom relief and long-term disease monitoring.
Infectious Disease and Vaccine Research
Another important area at this Bucharest site is bacterial infection prevention, including studies in healthy infants and toddlers for meningococcal vaccination. These trials are designed to confirm immune response and help strengthen protection against serious invasive infection.
- Evaluating a meningococcal vaccine for immune response and protection in young children
- Supporting prevention-focused research in bacterial infection and public health
- Assessing whether vaccination strategies can improve infectious disease control
The work reflects a broader commitment to preventive medicine alongside treatment-focused studies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 10 therapeutic areas and 15 of 22 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Ipsen Bioscience Inc.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Chiesi Farmaceutici S.p.A.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sana Monitoring S.R.L.
lock Showing 1 of 12 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles. | Chemo Research S.L. | Phase III | Not Recruiting | Jul 2023 | Aug 2025 |
IMP list
lock Showing 1 of 22 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Beclometasone Dipropionate Anhydrous | 2 | Unknown | 2022-04-22 | 2024-01-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.